| 5JLJ | date | ![]() |
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||||||
| compound | source | ||||||||||||||||||
| symmetry |
| ||||||||||||||||||
| crystal cell |
| ||||||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||||||
| ligand | 6L8, CL, GNP, GOL, MG | enzyme |
| ||||||||||||||||
| Gene Ontology |
| ||||||||||||||||||
| Primary reference | Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies., Hing ZA, Fung HY, Ranganathan P, Mitchell S, El-Gamal D, Woyach JA, Williams K, Goettl VM, Smith J, Yu X, Meng X, Sun Q, Cagatay T, Lehman AM, Lucas DM, Baloglu E, Shacham S, Kauffman MG, Byrd JC, Chook YM, Garzon R, Lapalombella R, Leukemia. 2016 Jun 21. doi: 10.1038/leu.2016.136. PMID:27323910 | ||||||||||||||||||
| Data retrieval |
![]() |
| View 5JLJ in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |